↓ Skip to main content

Hands on Alemtuzumab-experience from clinical practice: whom and how to treat

Overview of attention for article published in Multiple Sclerosis and Demyelinating Disorders, August 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Hands on Alemtuzumab-experience from clinical practice: whom and how to treat
Published in
Multiple Sclerosis and Demyelinating Disorders, August 2016
DOI 10.1186/s40893-016-0011-1
Authors

Lina Hassoun, Judith Eisele, Katja Thomas, Tjalf Ziemssen

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 18%
Other 4 12%
Student > Doctoral Student 3 9%
Student > Ph. D. Student 3 9%
Student > Bachelor 2 6%
Other 4 12%
Unknown 11 33%
Readers by discipline Count As %
Medicine and Dentistry 12 36%
Neuroscience 3 9%
Biochemistry, Genetics and Molecular Biology 2 6%
Nursing and Health Professions 1 3%
Agricultural and Biological Sciences 1 3%
Other 1 3%
Unknown 13 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 August 2016.
All research outputs
#2,952,079
of 22,881,964 outputs
Outputs from Multiple Sclerosis and Demyelinating Disorders
#3
of 22 outputs
Outputs of similar age
#56,473
of 366,909 outputs
Outputs of similar age from Multiple Sclerosis and Demyelinating Disorders
#3
of 5 outputs
Altmetric has tracked 22,881,964 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22 research outputs from this source. They receive a mean Attention Score of 3.3. This one scored the same or higher as 19 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,909 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.